MVCD2-RNAst

COMPOSITION OF THE DRUG

 NUCLEIC ACID - 1MG PER 1ML, SODIUM CHLORIDE 0.9%. AN IMPORTANT DIFFERENCE BETWEEN THE PLASMID PREPARATIONS MANUFACTURED BY OMSTAL PHARMA IS THE USE OF A UNIQUE PATENTED TRANSPORT SYSTEM OF OWN DEVELOPMENT. THIS SOLUTION INCREASES THE EFFECTIVENESS OF LOCAL EXPOSURE.

HOW TO USE

 THE MEDICINAL PRODUCT IS INTENDED FOR INTRAMUSCULAR ADMINISTRATION. SUBCUTANEOUS OR INTRAVENOUS ADMINISTRATION IS NOT ALLOWED. THE MEDICATION IS GIVEN USING THE USUAL INJECTION METHOD, THE NEEDLE DEPTH IS AT LEAST 1 CM.

 DRUG POTENCY INCREASES BY 150-200% WITH FREQUENT SINGLE DOSE FRACTIONAL ADMINISTRATION. FOR EXAMPLE, ON A 2 CM AREA OF SKIN, 1 ML OF THE ACTIVE VOLUME OF THE DRUG IS INJECTED IN THE FORM OF 5 INJECTIONS OF 0.2 ML EACH.

 IN ORDER TO STIMULATE THE GROWTH OF MUSCLE TISSUE, THE DRUG MUST BE INJECTED INTO THE MUSCLE YOU WANT TO ENLARGE. IN ORDER TO STIMULATE THE FUSION OF LANDAGES AND DAMAGED CARTILAGE, IT IS NECESSARY TO MAKE INJECTIONS AT THE SITE OF INJURY, INJECTING THE DRUG INTO THE MUSCLE TISSUE. TO REPAIR THE DAMAGED NERVE, AN INJECTION MUST BE MADE INTO THE MUSCLE TISSUE AROUND THE NERVE.

 DRUG EFFICACY INCREASES UP TO 1000% WHEN ADMINISTRATED BY ELECTROPORATION. PARAMETERS OF ELECTROPORATION: SHOCK - NOT LESS THAN 200 VOLTS, DURATION - 1 MILLISECONDS, DISTANCE BETWEEN THE INSERTED ELECTRODES - NOT MORE THAN 1.5 CM.